Endectocides for Malaria Control
用于控制疟疾的杀虫剂
基本信息
- 批准号:7512454
- 负责人:
- 金额:$ 14.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdultAfrica South of the SaharaAfricanAgeAgonistAgricultureAnopheles GenusAnopheles gambiaeAreaBionomicsBloodCharacteristicsChloride ChannelsCitiesClassCommunitiesCulicidaeDeveloped CountriesDeveloping CountriesDevelopmentDoseDrug toxicityExhibitsFeeding behaviorsFemaleFilarial ElephantiasesFogsGenerationsGlutamatesHabitsHealthHelminthsHousingHumanInfectionInsecticide ResistanceInsecticidesIvermectinLactonesLinkLogistic RegressionsMalariaMalathionMammalsMeasuresMembraneMethodsModelingMolecular TargetNematodaNeuromuscular JunctionOnchocerciasisPesticidesPharmaceutical PreparationsPlasmodiumPopulationPropertyPublic HealthRateResearchResistanceRestSafetyScoreSenegalSporozoitesStructureSurvival RateSurvivorsTestingTimeTreatment Protocolscostdaydisease transmissiondrug testingeggfeedingkillingsmathematical modelmilbemycinmilbemycinsmosquitocidalmoxidectinnovelpreventpyrethroidresearch studystemtransmission processvector
项目摘要
DESCRIPTION (provided by applicant): Malaria continues to sicken and kill millions of people around the world every year, and is an especially intractable problem in sub-Saharan Africa. Mosquito adulticides are the bedrock of effective malaria control because they are relatively cost-effective, they can be applied to walls or bednets, and they target the most critical variable in malaria transmission models, adult mosquito survivor rates. However, widespread insecticide resistance and continued malaria transmission require the development of novel adulticides and novel ways to apply them. Endectocides are broad spectrum, low toxicity drugs with combined anti-helminthic and anti-ectoparasitic properties and are currently given to human populations for onchocerciasis and lymphatic filariasis control. Current endectocides that act as agonists to glutamate and GABA-gated chloride ion channels in mosquito myoneural junctions, could also be effectively used for malaria control in sub- Saharan Africa and would have certain major advantages over other adulticides due to their molecular targets, how they would be administered to the human population, and the bionomics of African malaria vectors. This research is intended to determine the effective doses of glutamate and GABA-gated chloride ion channel agonist endectocides (macrocyclic lactones, milbemycins, nodulasporamides) for killing adult Anopheles spp. when administered via an artificial bloodmeal. Secondly, mass-ivermectin administration for onchocerciasis control in Southeastern Senegal will be tested for mosquitocidal effects on bloodfeeding adult Anopheles spp. in the field, and that this effect will transiently interrupt malaria transmission in the local community. PUBLIC HEALTH RELEVANCE This project seeks to develop novel methods to control malaria in sub-Saharan Africa by evaluating current anti-helminth drugs for activity against African malaria vectors and testing their effects in a natural field experiment.
描述(由申请人提供):疟疾每年继续使全世界数百万人患病和死亡,这是撒哈拉以南非洲地区一个特别棘手的问题。灭蚊剂是有效控制疟疾的基础,因为它们相对具有成本效益,可以应用于墙壁或蚊帐,并且针对疟疾传播模式中最关键的变量,即成蚊存活率。然而,广泛的杀虫剂耐药性和持续的疟疾传播需要开发新的杀菌剂和新的施用方法。杀内灭剂是广谱、低毒的药物,具有抗寄生虫和抗体外寄生虫的综合特性,目前用于控制盘尾丝虫病和淋巴丝虫病。目前的灭虫剂作为激动剂作用于蚊子肌神经连接中的谷氨酸和gaba门控氯离子通道,也可以有效地用于撒哈拉以南非洲的疟疾控制,并且由于其分子靶点、对人群的施用方式以及非洲疟疾媒介的生物学特性,与其他灭虫剂相比,它们具有一定的主要优势。本研究旨在确定谷氨酸和gaba门控氯离子通道激动剂(大环内酯、米贝霉素、球孢酰胺)通过人工血粉杀灭成年按蚊的有效剂量。其次,将在塞内加尔东南部对用于控制盘尾丝虫病的伊维菌素大规模施用进行实地测试,以确定对吸血成年按蚊的杀蚊效果,以及这种效果将暂时阻断疟疾在当地社区的传播。本项目旨在通过评估目前抗寄生虫药物对非洲疟疾病媒的活性并在自然实地试验中测试其效果,开发控制撒哈拉以南非洲疟疾的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN David FOY其他文献
BRIAN David FOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN David FOY', 18)}}的其他基金
West Nile virus control through mosquitocidal avian bloodmeals
通过杀蚊禽血粉控制西尼罗河病毒
- 批准号:
10674117 - 财政年份:2020
- 资助金额:
$ 14.7万 - 项目类别:
West Nile virus control through mosquitocidal avian bloodmeals
通过杀蚊禽血粉控制西尼罗河病毒
- 批准号:
10454977 - 财政年份:2020
- 资助金额:
$ 14.7万 - 项目类别:
West Nile virus control through mosquitocidal avian bloodmeals
通过杀蚊禽血粉控制西尼罗河病毒
- 批准号:
10267766 - 财政年份:2020
- 资助金额:
$ 14.7万 - 项目类别:
Repeat Ivermectin Mass Drug Administrations for MALaria control II (RIMDAMAL II): a double-blind cluster randomized trial for integrated control of malaria
重复伊维菌素大规模药物管理用于疟疾控制 II (RIMDAMAL II):疟疾综合控制的双盲整群随机试验
- 批准号:
9754784 - 财政年份:2018
- 资助金额:
$ 14.7万 - 项目类别:
Repeat Ivermectin Mass Drug Administrations for MALaria control II (RIMDAMAL II): a double-blind cluster randomized trial for integrated control of malaria
重复伊维菌素大规模药物管理用于疟疾控制 II (RIMDAMAL II):疟疾综合控制的双盲整群随机试验
- 批准号:
10468728 - 财政年份:2018
- 资助金额:
$ 14.7万 - 项目类别:
Repeat Ivermectin Mass Drug Administrations for MALaria control II (RIMDAMAL II): a double-blind cluster randomized trial for integrated control of malaria
重复伊维菌素大规模药物管理用于疟疾控制 II (RIMDAMAL II):疟疾综合控制的双盲整群随机试验
- 批准号:
10223135 - 财政年份:2018
- 资助金额:
$ 14.7万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




